فهرست مقالات منتشره مطالعه کوهورت  گلستان در مجلات معتبر بین المللی جهان:

 

 

نتایج اولیه و امکان سنجی اجرایی مطالعه در سال 2005:

 

Pourshams A, Saadatian-Elahi M, Nouraie M, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R. Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer. 2005 Jan 17;92(1):176-81.

 

 

پروفایل مطالعه:

 

Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, Jafari E, Rakhshani N, Salahi R, Semnani S, Kamangar F, Abnet CC, Ponder B, Day N, Dawsey SM, Boffetta P, Malekzadeh R. Cohort Profile: The Golestan Cohort Study --a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol. 2010 Feb;39(1):52-9

 

تشریح ساختار و دستاوردهای مطالعه :

 

 Sepanlou SG, Etemadi A, Kamangar F, Sepehr A, Pourshams A, Poustchi H, Islami F, Sadjadi A, Nasrollahzadeh D, Semnani S, Saidi F, Abnet CC, Ponder B, Pharoah PD, Day NE, Brennan P, Boffetta P, Dawsey SM, Malekzadeh R. The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med. 2013 Jan;16(1):46-53.

 

 

:فهرست برخی از مهمترین مقالات که در ابتدای مطالعه کوهورت گلستان منتشر شدند

 

  1. Saidi F, Sepehr A, Fahimi S, Farahvash MJ, Salehian P, Esmailzadeh A, et al. Oesophageal cancer among the Turkomans of northeast Iran. Br J Cancer. 2000; 83(9): 1249 – 1254
  2. Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, et al. Declining incidence of esophageal cancer in the
  3. Turkmen Plain, Eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev. 2006; 30(1): 14 – 19.
  4. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett. 2006; 240(1): 143 – 147.
  5. Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, Mousavi SM, et al. Gastric cancer in Ardabil, Iran–a review and update on cancer registry data. Asian Pac J Cancer Prev. 2010; 11(3): 595 – 599.
  6. Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, Bahadori M. Cancer registry in Iran: a brief overview. Arch Iran Med. 2008; 11(5): 577 – 580.
  7. Sadjadi A, Hislop TG, Bajdik C, Bashash M, Ghorbani A, Nouraie M, et al. Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada. BMC Cancer. 2009; 9: 381.
  8. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population- based cancer registry from Iran. Int J Cancer. 2003; 107(1): 113 – 118.
  9. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005; 6(3): 359– 363.
  10. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer. 2004; 90(7): 1402 – 1406.
  1. Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffetta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran – a review. Eur J Cancer. 2009; 45(18): 3156 – 3165.
  2. Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12(6): 576 – 583.
  3. Taghavi N, Nasrollahzadeh D, Merat S, Yazdanbod A, Hormazdi M, Sotoudeh M, et al. Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases. World J Gastroenterol. 2007; 13(40): 5367 – 5370.
  4. Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev. 2004; 13(6): 1068 – 1070.
  5. Nouraie M, Pourshams A, Kamangar F, Sotoudeh M, Derakhshan MH, Akbari MR, et al. Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol. 2004; 10(17): 2544 – 2546.
  6. Sepehr A, Kamangar F, Abnet CC, Fahimi S, Pourshams A, Poustchi H, et al. Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett. 2004; 213(2): 195 – 202.
  7. Sepehr A, Taniere P, Martel-Planche G, Zia’ee AA, Rastgar-Jazii F, Yazdanbod M, et al. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene. 2001;23.
  8. Marjani HA, Biramijama l F, Rakhshani N, Hossein-Nezhad A, Malekzadeh R. Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran. Genet Mol Res. 2010; 9(1): 239 – 249.
  9. Kamangar F, Strickland PT, Pourshams A, Malekzadeh R, Boffetta P, Roth MJ, et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res. 2005; 25(1B): 425 – 428.
  10. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Sun P, Islami F, et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer. 2006; 119(5): 1047 – 1051.
  11. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008; 98(11): 1857 – 1863.
  12. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008; 17(11): 3062 – 3068.
  13. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ. 2009; 338: b929.
  14. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009; 38(4): 978 – 988.
  15. Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, Abnet CC, et al. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut. 2010. 59(9): 1178 – 1183.
  16. Derakhshan MH, Malekza deh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008. 57(3): 298 – 305.
  17. Derakhshan MH, Yazdanb od A, Sadjadi AR, Shokoohi B, McColl KE, Malekzadeh R. High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut. 2004; 53(9): 1262– 1266.
  18. Roshandel G, Sadjadi A , Aarabi M, Keshtkar A, Sedaghat SM, Nouraie SM, et al. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med. 2012; 15(4): 196 – 200.
  19. Khademi H, Kamangar F. Esophageal cancer incidence trends in northeastern Iran: comparing rates over 36 years. Arch Iran Med. 2012; 15(4): 194 – 195.
  20. Shakeri R, Kamangar F, Nasrollahzadeh D, Nouraie M, Khademi H, Etemadi A, et al. Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PloS One. 2012; 7(3): e32711.
  21. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. Opium; an emerging risk factor for gastric adenocarcinoma. Int J Cancer. 2013; Jul 15;133(2):455-61.
  22. Islami F, Malekshah AF , Kimiagar M, Pourshams A, Wakefield J, Goglani G, et al. Patterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer. Nutr Cancer. 2009; 61(4):475 – 483.
  23. Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran- -a population based study. Int J Cancer. 2009; 125(8): 1953 – 1960.
  24. Marjani HA, Biramijama l F, Hossein-Nezhad A, Islami F, Pourshmas A, Semnani S. Prevalence of esophageal cancer risk factors among Turkmen and non-Turkmen ethnic groups in a high incidence area in Iran. Arch Iran Med. 2010; 13(2): 111 – 115.
  25. Nasrollahzadeh D, Male kzadeh R, Aghcheli K, Sotoudeh M, Merat S, Islami F, et al. Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit. Br J Cancer. 2012; 107(5): 888 – 894.
  26. Islami F, Boffetta P, van Schooten FJ, Strickland P, Phillips DH, Pourshams A, et al. Exposure to Polycyclic Aromatic Hydrocarbons Among Never Smokers in Golestan Province, Iran, an Area of High Incidence of Esophageal Cancer – a Cross-Sectional Study with Repeated Measurement of Urinary 1-OHPG in Two Seasons. Front Oncol. 2012; 2: 14.
  27. Roshandel G, Semnani S , Malekzadeh R, Dawsey SM. Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. Arch Iran Med. 2012; 15(11): 713 – 722.
  28. Etemadi A, Islami F, P hillips DH, Godschalk R, Golozar A, Kamangar F, et al. Variation in PAH-related DNA adduct levels among nonsmokers: The role of multiple genetic polymorphisms and nucleotide excision repair phenotype; Int J Cancer. 2013 Jun 15;132(12):2738-47
  29. Nasrollahzadeh D, Aghc heli K, Sotoudeh M, Shakeri R, Persson EC, Islami F, et al. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PloS One. 2011; 6(10): e26957.
  30. Sitas F, Egger S, Urba n MI, Taylor PR, Abnet CC, Boffetta P, et al. InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst. 2012; 104(2): 147 – 158.
  31. Etemadi A, Abnet CC, G olozar A, Malekzadeh R, Dawsey SM. Modeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran. Arch Iran Med. 2012; 15(1): 18– 21.
  32. Etemadi A, Kamangar F, Islami F, Poustchi H, Pourshams A, Brennan P, Boffetta P, Malekzadeh R, Dawsey SM, Abnet CC, Emadi A. Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study. BMC Med. 2015 Jan 15;13:8.
  33. Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, Fakheri H, Saadatnia H, Ghavamnasiri MR, Malekzadeh R. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev. 2006;30(1):14-9.

 

فهرست برخی مقالات مرتبط با سرطان های دستگاه گوارش (مری و معده)  در مطالعه کوهورت گلستان:

 

نخستین مقالات چاپ شده بر مبنای نتایج مطالعه کوهورت گلستان، بر انواعی از حیطه های علمی سرطان های گوارشی  از جمله اپیدمیولوژی سرطانها، عوامل خطر محیطی و رفتاری، ابعاد بالینی، و حیطه های مرتبط با پاتولوژی و ابعاد سلولی مولکولی و حتی ژنتیکی این سرطانها متمرکز بودند . در این مطالعات، عوامل خطر جدید مرتبط با سرطانهای گوارشی  از جمله تریاک، نوشیدنی های پرحرارت (چای داغ)، و بهداشت دهان و دندان مطرح و برجسته شده اند که فهرست ذیل، جدیدترین این مطالعات است:

 

  1. Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, Mirminachi B, Nasseri-Moghaddam S, Semnani S, Shakeri R, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharaoh PD, Brennan P, Abnet CC, Boffetta P, Kamangar F, Malekzadeh R. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 2017 Dec 20. pii: cebp.0592.2017. doi: 10.1158/1055-9965.EPI-17-0592. [Epub ahead of print]
  2. Hashemian M, Murphy G, Etemadi A, Poustchi H, Brockman JD, Kamangar F, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Brennan PJ, Boffetta P, Hekmatdoost A, Malekzadeh R, Abnet CC. Toenail mineral concentration and risk of esophageal squamous cell carcinoma, results from the Golestan Cohort Study. Cancer Med. 2017 Dec;6(12):3052-3059.
  3. Hashemian M, Poustchi H, Abnet CC, Boffetta P, Dawsey SM, Brennan PJ, Pharoah P, Etemadi A, Kamangar F, Sharafkhah M, Hekmatdoost A, Malekzadeh R. Dietary intake of minerals and risk of esophageal squamous cell carcinoma: results from the Golestan Cohort Study. Am J Clin Nutr. 2015 Jul;102(1):102-8.
  4. Golozar A, Etemadi A, Kamangar F, Fazeltabar Malekshah A, Islami F, Nasrollahzadeh D, Abedi-Ardekani B, Khoshnia M, Pourshams A, Semnani S, Marjani HA, Shakeri R, Sotoudeh M, Brennan P, Taylor P, Boffetta P, Abnet C, Dawsey S, Malekzadeh R. Food preparation methods, drinking water source, and esophageal squamous cell carcinoma in the high-risk area of Golestan, Northeast Iran. Eur J Cancer Prev. 2016 Mar;25(2):123-9.
  5. Roshandel G, Merat S, Sotoudeh M, Khoshnia M, Poustchi H, Lao-Sirieix P, Malhotra S, O'Donovan M, Etemadi A, Nickmanesh A, Pourshams A, Norouzi A, Debiram I, Semnani S, Abnet CC, Dawsey SM, Fitzgerald RC, Malekzadeh R. Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran. Br J Cancer. 2014 Dec 9;111(12):2235-41.
  6. Keeley BR, Islami F, Pourshams A, Poustchi H, Pak JS, Brennan P, Khademi H, Genden EM, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R, Sikora AG. Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer. Cancer Sci. 2014 Sep;105(9):1205-11.
  7. Roshandel G, Khoshnia M, Sotoudeh M, Merat S, Etemadi A, Nickmanesh A, Norouzi A, Pourshams A, Poustchi H, Semnani S, Ghasemi-Kebria F, Noorbakhsh R, Abnet C, Dawsey SM, Malekzadeh R. Endoscopic screening for precancerous lesions of the esophagus in a high risk area in Northern Iran. Arch Iran Med. 2014 Apr;17(4):246-52.
  8. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Abedi-Ardekani B, Khoshnia M, Islami F, Pourshams A, Pawlita M, Boffetta P, Dawsey SM, Kamangar F, Abnet CC. Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res (Phila). 2013 May;6(5):477-82.
  9. Etemadi A, Abnet CC, Golozar A, Malekzadeh R, Dawsey SM. Modeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran. Arch Iran Med. 2012 Jan;15(1):18-21.
  10. Aghcheli K, Marjani HA, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M, Abedi-Ardekani B, Ghavamnasiri MR, Razaei E, Khalilipour E, Mohtashami S, Makhdoomi Y, Rajabzadeh R, Merat S, Sotoudehmanesh R, Semnani S, Malekzadeh R. Prognostic factors for esophageal squamous cell carcinoma--a population-based study in Golestan Province, Iran, a high incidence area. PLoS One. 2011;6(7):e22152.
  11. Islami F, Malekshah AF, Kimiagar M, Pourshams A, Wakefield J, Goglani G, Rakhshani N, Nasrollahzadeh D, Salahi R, Semnani S, Saadatian-Elahi M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R. Patterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer. Nutr Cancer. 2009;61(4):475-83.
  1. Islami F, Kamangar F, Nasrollahzadeh D, Møller H, Boffetta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer. 2009 Dec;45(18):3156-65.
  2. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet CC, Brennan P, Møller H, Saidi F, Dawsey SM, Malekzadeh R, Boffetta P. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ. 2009 Mar 26;338:b929.

 

:فهرست مقالات سایر بیماری های گوارشی، هپاتولوژی و رادیولوژی مطالعه کوهورت گلستان

 

  1. Poustchi H, Katoonizadeh A, Ostovaneh MR, Moossavi S, Sharafkhah M, Esmaili S, Pourshams A, Mohamadkhani A, Besharat S, Merat S, Mohamadnejad M, George J, Malekzadeh R. Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern Iran​. Middle East J Dig Dis. 2014 Oct;6(4):186-94.

  1. Radmard AR, Poustchi H, Hashemi Taheri AP, Gerami Seresht M, Mohammadinejad P, Yoonessi A, Dadgostar M, Rahmanian MS, Jafari E, Zeinoddini A, Malekzadeh R, Merat S. Central Obesity and Liver Iron Content: A Noninvasive Assessment in General Population by Magnetic Resonance Imaging. Ann Nutr Metab. 2016;69(3-4):181-189.
  2. Radmard AR, Rahmanian MS, Abrishami A, Yoonessi A, Kooraki S, Dadgostar M, Hashemi Taheri AP, Gerami Seresht M, Poustchi H, Jafari E, Malekzadeh R, Merat S. Assessment of Abdominal Fat Distribution in Non-Alcoholic Fatty Liver Disease by Magnetic Resonance Imaging: a Population-based Study. Arch Iran Med. 2016 Oct;19(10):693-699.
  3. Katoonizadeh A, Sharafkhah M, Ostovaneh MR, Norouzi A, Khoshbakht N, Mohamadkhani A, Eslami L, Gharravi A, Shayanrad A, Khoshnia M, Esmaili S, George J, Poustchi H, Malekzadeh R. Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.J Viral Hepat. 2016 Oct;23(10):805-11.
  4. Radmard AR, Poustchi H, Ansari L, Khorasanizadeh F, Yoonessi A, Hashemi Taheri AP, Rahmanian MS, Jafari E, Malekzadeh R, Merat S. Abdominal fat distribution and carotid atherosclerosis in a general population: a semi-automated method using magnetic resonance imaging. Jpn J Radiol. 2016 Jun;34(6):414-22.
  5. Besharat S, Poustchi H, Mohamadkhani A, Roshandel G, Freedman ND, Merat S, Malekzadeh R. Central Obesity and Advanced Liver Stiffness in Hepatitis B: Result from Golestan Hepatitis B Cohort Study. Arch Iran Med. 2015 Sep;18(9):562-6.
  6. Radmard AR, Merat S, Kooraki S, Ashraf M, Keshtkar A, Sharafkhah M, Jafari E, Malekzadeh R, Poustchi H. Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences. Ann Hepatol. 2015 Sep-Oct;14(5):702-9.
  7. Besharat S, Poustchi H, Mohamadkhani A, Katoonizadeh A, Moradi A, Roshandel G, Freedman ND, Malekzadeh R. Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran. Hepat Mon. 2015 Feb 21;15(2):e23875.
  8. Radmard AR, Poustchi H, Dadgostar M, Yoonessi A, Kooraki S, Jafari E, Hashemi Taheri AP, Malekzadeh R, Merat S. Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mapping.Acad Radiol. 2015 Jun;22(6):714-21.
  9. Islami F, Pourshams A, Nasseri-Moghaddam S, Khademi H, Poutschi H, Khoshnia M, Norouzi A, Amiriani T, Sohrabpour AA, Aliasgari A, Jafari E, Semnani S, Abnet CC, Pharaoh PD, Brennan P, Kamangar F, Dawsey SM, Boffetta P, Malekzadeh R. Gastroesophageal Reflux Disease and overall and Cause-specific Mortality: A Prospective Study of 50000 Individuals. Middle East J Dig Dis. 2014 Apr;6(2):65-80.
  10. Islami F, Nasseri-Moghaddam S, Pourshams A, Poustchi H, Semnani S, Kamangar F, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Malekzadeh R. Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals.  PLoS One. 2014 Feb 21;9(2):e89256.
  11. Poustchi H, Esmaili S, Mohamadkhani A, Nikmahzar A, Pourshams A, Sepanlou SG, Merat S, Malekzadeh R. The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohortpopulation study. PLoS One. 2011;6(8):e23830.

 

اعتبار سنجی ابزارهای اندازه گیری برای اتوپسی و پرسشنامه تواتر غذایی:

 

  1. Khademi H, Etemadi A, Kamangar F, Nouraie M, Shakeri R, Abaie B, Pourshams A, Bagheri M, Hooshyar A, Islami F, Abnet CC, Pharoah P, Brennan P, Boffetta P, Dawsey SM, Malekzadeh R. Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS One. 2010 Jun 17;5(6):e11183.
  2. Malekshah AF, Kimiagar M, Saadatian-Elahi M, Pourshams A, Nouraie M, Goglani G, Hoshiarrad A, Sadatsafavi M, Golestan B, Yoonesi A, Rakhshani N, Fahimi S, Nasrollahzadeh D, Salahi R, Ghafarpour A, Semnani S, Steghens JP, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R. Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr. 2006 Aug;60(8):971-7.
  3. Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, Taylor PR, Kamangar F, Dawsey SM, Malekzadeh R. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1068-70.

 

سیگار و تریاک

 

فهرست مقالات مرتبط با «بروز سرطان و افزایش مرگ و میر کلی و اختصاصی ناشی از مصرف سیگار و تریاک» منتشره در مجلات  معتبر پزشکی

 

  1. Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, Abaie B, Islami F, Nasseri-Moghaddam S, Etemadi A, Byrnes G, Abnet CC, Dawsey SM, Day NE, Pharoah PD, Boffetta P, Brennan P, Kamangar F. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ. 2012 Apr 17;344:e2502.
  2. Rahmati A, Shakeri R, Khademi H, Poutschi H, Pourshams A, Etemadi A, Khoshnia M, Sohrabpour AA, Aliasgari A, Jafari E, Islami F, Semnani S, Gharravi A, Abnet CC, Pharoah PDP, Brennan P, Boffetta P, Dawsey SM, Malekzadeh R, Kamangar F. Mortality from respiratory diseases associated with opium use: a population-based cohort study. Thorax. 2017 Nov;72(11):1028-1034.
  3. Etemadi A, Khademi H, Kamangar F, Freedman ND, Abnet CC, Brennan P, Malekzadeh RGolestanCohort Study Team. Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern Population: a CohortStudy of 50 000 individuals from Iran. Tob Control. 2017 Nov;26(6):674-682.
  4. Malekzadeh MM, Khademi H, Pourshams A, Etemadi A, Poustchi H, Bagheri M, Khoshnia M, Sohrabpour AA, Aliasgari A, Jafari E, Islami F, Semnani S, Abnet CC, Pharoah PD, Brennan P, Boffetta P, Dawsey SM, Malekzadeh R, Kamangar F. Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol. 2013 Nov;108(11):1757-65.
  5. Islami F, Pourshams A, Vedanthan R, Poustchi H, Kamangar F, Golozar A, Etemadi A, Khademi H, Freedman ND, Merat S, Garg V, Fuster V, Wakefield J, Dawsey SM, Pharoah P, Brennan P, Abnet CC, Malekzadeh R, Boffetta P. Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart. 2013 Feb;99(4):272-8.
  6. Etemadi A, Islami F, Phillips DH, Godschalk R, Golozar A, Kamangar F, Malekshah AF, Pourshams A, Elahi S, Ghojaghi F, Strickland PT, Taylor PR, Boffetta P, Abnet CC, Dawsey SM, Malekzadeh R, van Schooten FJ. Variation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotype. Int J Cancer. 2013 Jun 15;132(12):2738-47.

 

تغذیه

طی مطالعه کوهورت، یافته های بسیار مهمی در مورد تاثیر تغذیه بر سلامت حاصل شد. در این مقالات مرتبط با مطالعه کوهورت گلستان، ارتباط  برخی الگوهای غذایی، گروه ها و اقلام  غذایی و ریز مغذی ها با مرگ و میر و سرطان، بررسی شده است. به عنوان مثال ،  مطالعه کوهورت گلستان نشان داد که در جمعیت مورد مطالعه، کمبود کلسیم و روی با سرطان مری مرتبط است.  الگوی غذایی سالم (HEI)، مصرف آجیل و لبنیات کم چرب و تخم مرغ با کاهش مرگ و میر در جمعیت کوهورت گلستان در ارتباط بوده است؛ در حالی که  که مصرف گوشت قرمز با مرگ و میر ارتباط ندارد. با توجه به الگوی متفاوت غذایی در ایران نسبت به کشورهای غربی، ارتباط رژیم غذایی و بیماری ها باید در جامعه ایران مورد بررسی قرار گیرد و مطالعه کوهورت گلستان این فرصت را برای پژوهشگران فراهم ساخته که به مطالعه ارتباط رژیم غذایی و بیماری ها بپردازند. در حال حاضر ارتباط انواع الگوهای غذایی و مرگ ومیر در حال بررسی است و نتایج آن اطلاعات ارزشمندی در اختیار سیاستگذاران حوزه تغدیه و دفتر بهبود تغذیه وزارت بهداشت قرار خواهد داد.

 

فهرست مقالات مرتبط با تغذیه، منتشره از مطالعه کوهورت گلستان در مجلات معتبر بین المللی:

 

  1. Malekshah AF, Kimiagar M, Pourshams A, Yazdani J, Kaiedi Majd S, Goglani G, et al. Vitamin deficiency in Golestan Province, northern Iran: a high-risk area for esophageal cancer. Arch Iran Med. 2010; 13(5): 391 – 394.
  2. Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, Khoshnia M, Farvid M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Pharoah PD, Boffetta P, Willett WC, Malekzadeh R. Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The GolestanCohort Study. Am J Epidemiol. 2017 Apr 15;185(8):697-711.
  3. Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, Khoshnia M, Farvid M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Pharoah PD, Boffetta P, Willett WC, Malekzadeh R. Dietary Protein Sources and All-Cause and Cause-Specific Mortality: The Golestan Cohort Study in Iran. Am J Prev Med. 2017 Feb;52(2):237-248.
  4. Fazel-Tabar Malekshah A, Zaroudi M, Etemadi A, Islami F, Sepanlou S, Sharafkhah M, Keshtkar AA, Khademi H, Poustchi H, Hekmatdoost A, Pourshams A, Feiz Sani A, Jafari E, Kamangar F, Dawsey SM, Abnet CC, Pharoah PD, Berennan PJ, Boffetta P, Esmaillzadeh A, Malekzadeh R. The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan CohortStudy. Arch Iran Med. 2016 Nov;19(11):752-761.
  5. Eslamparast T, Sharafkhah M, Poustchi H, Hashemian M, Dawsey SM, Freedman ND, Boffetta P, Abnet CC, Etemadi A, Pourshams A, Malekshah AF, Islami F, Kamangar F, Merat S, Brennan P, Hekmatdoost A, Malekzadeh R. Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study. Int J Epidemiol. 2017 Feb 1;46(1):75-85.
  6. Hashemian M, Poustchi H, Pourshams A, Khoshnia M, Brockman JD, Hekmatdoost A, Abnet CC, Malekzadeh R. The Nail as a Biomonitor of Trace Element Status in Golestan Cohort Study. Middle East J Dig Dis. 2016 Jan;8(1):19-23.
  7. Malekshah AF, Kimiagar M, Pourshams A, Yazdani J, Kaiedi Majd S, Goglani G, Jaafari E, Semnani S, Malekzadeh R. Vitamin deficiency in Golestan Province, northern Iran: a high-risk area for esophageal cancer. Arch Iran Med. 2010 Sep;13(5):391-4.
  8. Hashemian M, Murphy G, Etemadi A, Poustchi H, Brockman JD, Kamangar F, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Brennan PJ, Boffetta P, Hekmatdoost A, Malekzadeh R, Abnet CC. Toenail mineral concentration and risk of esophageal squamous cell carcinoma, results from the Golestan Cohort Study. Cancer Med. 2017 Dec;6(12):3052-3059.
  9. Hashemian M, Poustchi H, Abnet CC, Boffetta P, Dawsey SM, Brennan PJ, Pharoah P, Etemadi A, Kamangar F, Sharafkhah M, Hekmatdoost A, Malekzadeh R. Dietary intake of minerals and risk of esophageal squamous cell carcinoma: results from the Golestan Cohort Study. Am J Clin Nutr. 2015 Jul;102(1):102-8.
  10. Ghorbani Z, Hekmatdoost A, Zinab HE, Farrokhzad S, Rahimi R, Malekzadeh R, et al. Dietary food groups intake and cooking methods associations with pancreatic cancer: a case-control study. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2015;34(3):225-32.
  11. Islami F, Malekshah AF, Kimiagar M, Pourshams A, Wakefield J, Goglani G, Rakhshani N, Nasrollahzadeh D, Salahi R, Semnani S, Saadatian-Elahi M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R. Patterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer. Nutr Cancer. 2009;61(4):475-83.

 

چاقی و اضافه وزن:

روند افزایش چاقی و اضافه وزن در ایران هراس انگیز شده به طوری که از سال ۱۹۸۰ تا ۲۰۱۵، شیوع اضافه وزن در زنان بالغ از ۳۱٫۷ درصد به ۳۲٫۳ درصد و در مردان بالغ از ۲۳٫۹ درصد به ۳۵٫۳ درصد رسیده است. در همین فاصله زمانی، شیوع چاقی در زنان از ۱۶٫۶ درصد به ۲۴٫۱ درصد و در مردان از ۵٫۸  به ۱۳٫۸ درصد افزایش پیدا کرده است. اضافه وزن و چاقی استاندارد شده سنی در کودکان دختر و پسر نیز در مجموع از ۶٫۷ درصد به ۱۳٫۹ درصد افزایش پیدا کرده است.  این خطر شیوع چاقی و اضافه وزن در ایران در حالیست که طبق نتایج مطالعه  Global Health Effects of Overweight and Obesity ، در ایران شاهد افزایش بیش از دو برابری میزان مرگ و میر منتسب به اضافه وزن و چاقی هستیم.

 

فهرست مقالات مرتبط با «چاقی و اضافه وزن ، میزان شیوع و تاثیر آن در بروز بیماری های قلبی عروقی و سایر بیماری ها» منتشره از مطالعه کوهورت گلستان:

 

  1. Etemadi A, Abnet CC, Kamangar F, Islami F, Khademi H, Pourshams A, Poustchi H, Bagheri M, Sohrabpour AA, Aliasgar A, Khoshnia M, Wacholder S, Matthews CC, Pharoah PD, Brennan P, Boffetta P, Malekzadeh R, Dawsey SM. Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol. 2014 Feb;29(2):95-109.
  2. Keshtkar AA, Semnani S, Pourshams A, Khademi H, Roshandel G, Boffetta P, Malekzadeh R. Pictogram use was validated for estimating individual's body mass index. J Clin Epidemiol. 2010 Jun;63(6):655-9.

  1. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, Brennan P, Boffetta P, Malekzadeh R. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006 Jun 20;6:158.

  1. Etemadi A, Golozar A, Kamangar F, Freedman ND, Shakeri R, Matthews C, et al. Large body size and sedentary lifestyle during childhood and early adulthood and esophageal squamous cell carcinoma in a high-risk population. Annals of Oncology. 2012;23(6):1593-600.

  1. Garg VP, Vedanthan R, Islami F, Pourshams A, Poutschi H, Khademi H, Naeimi M, Malekshah AF, Jafari E, Salahi R, Kamangar F, Etemadi A, Pharoah PD, Abnet CC, Brennan P, Dawsey SM, Fuster V, Boffetta P, Malekzadeh R. Heart Disease Is Associated With Anthropometric Indices and Change in Body Size Perception Over the Life Course: The Golestan Cohort Study. Glob Heart. 2015 Dec;10(4):245-254.

 

بهداشت دهان و دندان:

 

امروزه نقش بهداشت دهان و دندان در پیشگیری از بروز برخی بیماری ها به اثبات رسیده و تعدادی از مطالعات در جهان، ارتباط میان بهداشت دهان و دندان و مرگ و میر به علل خاص را نشان داده‌‌اند؛ اما این مطالعات عمدتا در کشورهای پردرآمد انجام شده‌اند. مطالعات دانشمندان ایرانی تحت عنوان Oral health and mortality in the GOLESTAN Cohort Study که در نشریه معتبر بین‌المللی  International Journal of Epidemiology (نشریه انجمن بین المللی اپیدمیولوژی) منتشر شده،‌ به بررسی ارتباط میان بهداشت دهان و دندان و بروز بیماری‌ها و مرگ و میر به علل خاص پرداخته و نتایج آن نشان داده است که بهداشت ضعیف دهان و دندان و مسواک نزدن، با بیماری های قلبی عروقی، سرطان‌ها و کاهش طول عمر در ارتباط است و افراد دارای دندان از دست رفته، خالی، فاسد، و پر شده، نسبت به افرادی که دندان‌های کمتری از دست داده‌اند، بیشتر در معرض مرگ‌ومیر به علل خاص هستند. 

 

فهرست مقالات مرتبط با بهداشت دهان و دندان ، حاصل از مطالعه کوهورت گلستان:

 

  1. Vogtmann E, Etemadi A, Kamangar F, Islami F, Roshandel G, Poustchi H, Pourshams A, Khoshnia M, Gharravi A, Brennan PJ, Boffetta P, Dawsey SM, Malekzadeh R, Abnet CC. Oral health and mortality in the Golestan Cohort Study. Int J Epidemiol. 2017 Dec 1;46(6):2028-2035.
  2. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Abedi-Ardekani B, Khoshnia M, Islami F, Pourshams A, Pawlita M, Boffetta P, Dawsey SM, Kamangar F, Abnet CC. Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res (Phila). 2013 May;6(5):477-82.

 


سایر بیماریهای مزمن غیرواگیر:

با پیشرفت مطالعه کوهورت گلستان، این نتیجه حاصل شد که سایر بیماریهای مزمن از جمله بیماریهای قلبی عروقی، دیابت، مزمن کلیوی عوامل مهمتری برای مرگ و میر در استان گلستان هستند.

 

  1. Ahmadi B, Alimohammadian M, Yaseri M, Majidi A, Boreiri M, Islami F, Poustchi H, Derakhshan MH, Feizesani A, Pourshams A, Abnet CC, Brennan P, Dawsey SM, Kamangar F, Boffetta P, Sadjadi A, Malekzadeh R. Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis. Medicine (Baltimore). 2016 Feb;95(7):e2756.

  1. Alimohammadian M, Majidi A, Yaseri M, Ahmadi B, Islami F, Derakhshan M, Delavari A, Amani M, Feyz-Sani A, Poustchi H, Pourshams A, Sadjadi AM, Khoshnia M, Qaravi S, Abnet CC, Dawsey S, Brennan P, Kamangar F, Boffetta P, Sadjadi A, Malekzadeh R. Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West Asia.BMJ Open. 2017 May 9;7(5):e013548.

 

 

فهرست مقالات مرتبط با داروی «پلی پیل»، در مطالعه کوهورت گلستان:

 

  1. Rastegarpanah M, Malekzadeh F, Thomas GN, Mohagheghi A, Cheng  KK, Marshall T. A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by “heart polypill”? Arch Iran Med. 2008; 11(3): 306 – 313.

  1. Malekzadeh F, Marshall T, Pourshams A, Gharravi M, Aslani A, Nateghi A, Rastegarpanah M, Khoshnia M, Semnani S, Salahi R, Thomas GN, Larijani B, Cheng KK, Malekzadeh R. A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. Int J Clin Pract. 2010 Aug;64 (9):1220-7 

  1. Majed M, Moradmand Badie S. A pilot double-blind randomized placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors. Arch Iran Med. 2011; 14(1): 78 – 80.

  1. Sepanlou SG, Farzadfar F, Jafari E, Danaei G. Cardiovascular disease prevention using fixed dose pharmacotherapy in iran: updated meta-analyses and mortality estimation. Archives of Iranian medicine. 2012; 15(9):531-7. Epub 2012/08/29.

  1. Merat S, Poustchi H, Hemming K, Jafari E, Radmard AR, Nateghi A, Shiravi Khuzani A, Khoshnia M, Marshall T, Malekzadeh R. PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort(PolyIran - Liver) - Study Protocol. Arch Iran Med. 2015 Aug;18(8):515-23.

  1. Ostovaneh MR, Poustchi H, Hemming K, Marjani H, Pourshams A, Nateghi A, Majed M, Navabakhsh B, Khoshnia M, Jaafari E, Mohammadifard N, Malekzadeh F, Merat S, Sadeghi M, Naemi M, Etemadi A, Thomas GN, Sarrafzadegan N, Cheng KK, Marshall T, Malekzadeh R. Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial. Eur J Prev Cardiol. 2015 Dec;22(12):1609-17.

  1. Roshandel G, Ostovaneh MR, Poustchi H, Malekzadeh F, Sepanlou SG, Honarvar MR, Semnani S, Merat S, Malekzadeh R. Reliability Analysis of a Newly Developed Questionnaire for Quality Control of Follow-up Visits in PolyIran Study. Arch Iran Med. 2016 Aug;19(8):551-5

 

 

مقالات مرتبط با بیماری های قلبی عروقی و فشار خون بالا در مطالعه کوهورت گلستان:

 

  1. Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, Pourshams A, Poustchi H, Navabakhsh B, Naemi M, Pharoah PD, Abnet CC, Brennan P, Boffetta P, Dawsey SM, Esteghamati A, Malekzadeh R. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens. 2013 Jul;31(7):1364-71.
  2. Sepanlou SG, Sharafkhah M, Poustchi H, Malekzadeh MM, Etemadi A, Khademi H, Islami F, Pourshams A, Pharoah PD, Abnet CC, Brennan P, Boffetta P, Dawsey SM, Esteghamati A, Kamangar F, Malekzadeh R. Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran. J Hum Hypertens. 2016 Apr;30(4):260-7
  3. Sepanlou SG, Malekzadeh R, Poustchi H, Sharafkhah M, Ghodsi S, Malekzadeh F, Etemadi A, Pourshams A, Pharoah PD, Abnet CC, Brennan P, Boffetta P, Dawsey SM, Kamangar F. The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of Iran. PLoS One. 2015 May 26;10(5):e0126779.
  4. Sepanlou SG, Newson RB, Poustchi H, Malekzadeh MM, Rezanejad Asl P, Etemadi A, Khademi H, Islami F, Pourshams A, Pharoah PD, Abnet CC, Brennan P, Bofetta P, Dawsey SM, Kamangar F, Malekzadeh R. Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran. Arch Iran Med. 2015 Mar;18(3):144-52.

  1. Garg VP, Vedanthan R, Islami F, Pourshams A, Poutschi H, Khademi H, Naeimi M, Malekshah AF, Jafari E, Salahi R, Kamangar F, Etemadi A, Pharoah PD, Abnet CC, Brennan P, Dawsey SM, Fuster V, Boffetta P, Malekzadeh R. Heart Disease Is Associated With Anthropometric Indices and Change in Body Size Perception Over the Life Course: The Golestan Cohort Study. Glob Heart. 2015 Dec;10(4):245-254.
  1. Mitter SS, Vedanthan R, Islami F, Pourshams A, Khademi H, Kamangar F, Abnet CC, Dawsey SM, Pharoah PD, Brennan P, Fuster V, Boffetta P, Malekzadeh R. Household Fuel Use and Cardiovascular Disease Mortality: Golestan Cohort Study. Circulation. 2016 Jun 14;133(24):2360-9.

 

مقالات مرتبط با دیابت در مطالعه کوهورت گلستان:

 

  1. Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health. 2017 Jan 31;17(1):133.
  2. Golozar A, Khademi H, Kamangar F, Poutschi H, Islami F, Abnet CC, Freedman ND, Taylor PR, Pharoah P, Boffetta P, Brennan PJ, Dawsey SM, Malekzadeh R, Etemadi A. Diabetes mellitus and its correlates in an Iranian adult population. PLoS One. 2011;6(10):e26725.

 

 

مقالات مرتبط با بیماری های مزمن کلیوی در مطالعه کوهورت گلستان:

 

  1. Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R, Hakemi MS, Pourshams A, Khoshnia M, Gharravi A, Broumand B, Nobakht-Haghighi A, Kalantar-Zadeh K, Malekzadeh R. Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study. PLoS One. 2017 May 3;12(5):e0176540.
  2. Najafi I, Attari F, Is lami F, Shakeri R, Malekzadeh F, Salahi R, et al. Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran. PLoS One. 2010; 5(12): e14216.
  3. Najafi I, Shakeri R, I slami F, Malekzadeh F, Salahi R, Yapan-Gharavi M, et al. Prevalence of chronic kidney disease and its associated risk factors: the

 

 

 

 

مطالعه جهانی بار بیماری ها

 

 

مطالعه جهاني بار بيماري‌ها ( Global Burden of Disease Study) دقیق ترین و جامع ترین مطالعه سالانه داوری شده از روند سلامت در جهان است که از سوی انستيتوي سنجش و ارزشيابي سلامت (Institute of Health Metrics and Evaluation) دانشگاه واشنگتن در شهر سياتل ايالات متحده و با مشارکت صدها محقق از سراسر جهان انجام می شود و تازه ترین برآوردها از مرگ و میر، بیماری ها و ناتوانی ها در کشورهای مختلف را گزارش می دهد. پژوهشکده بيماريهاي گوارش و کبد دانشگاه علوم پزشکی تهران نیز از سال ۲۰۱۰ (۱۳۸۹ شمسي)  با این مطالعه همکاری و در بیش از 70 مقاله از این مطالعه جهانی مشارکت داشته است که همگی این مقالات در مجلات بسیار معتبر پزشکی جهان به چاپ رسیده اند.

 

: مقالات مرتبط با بار بیماری ها در جهان

 

 

  1. GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017 Nov;16(11):877-897.
  2. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1345-1422.
  3. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1260-1344.
  4. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1211-1259.
  5. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1151-1210.
  6. GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1084-1150.
  7. GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1423-1459.
  8. GBD 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017 Jul 6;377(1):13-27.
  9. GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017 Jul 15;390(10091):231-266.
  10. GBD 2015 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017 Jul 4;70(1):1-25.
  11. Global Burden of Disease Health Financing Collaborator Network. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017 May 20;389(10083):2005-2030.
  12. Global Burden of Disease Health Financing Collaborator Network. Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017 May 20;389(10083):1981-2004.
  13. GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017 May 13;389(10082):1885-1906.
  14. Global Burden of Disease Child and Adolescent Health Collaboration. Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study. JAMA Pediatr. 2017 Jun 1;171(6):573-592.
  15. GBD 2015 Collaborators. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017 Jan 10;317(2):165-182.
  16. Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017 Apr 1;3(4):524-548.
  17. GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1775-1812.
  18. GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1725-1774.
  19. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1659-1724.
  20. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1603-1658.
  21. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602.
  22. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459-1544.
  23. GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1813-1850.
  24. GBD 2015 HIV Collaborators. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016 Aug;3(8):e361-e387.
  25. Global Burden of Disease Pediatrics Collaboration. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. JAMA Pediatr. 2016 Mar;170(3):267-87.
  26. GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Dec 5;386(10010):2287-323.
  27. GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Nov 28;386(10009):2145-91.
  28. Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer 2013. JAMA Oncol. 2015 Jul;1(4):505-27.
  29. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Aug 22;386(9995):743-800.
  30. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71.
  31. GBD 2013 Collaborators. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep 13;384(9947):1005-70.
  32. GBD 2013 Collaborators. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Aug 30;384(9945):766-81.
  33. GBD 2013 Collaborators. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep 13;384(9947):980-1004.
  34. GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015;45(3):161-76.
  35. GBD 2013 Stroke Panel Experts Group. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013. Neuroepidemiology. 2015;45(3):177-89.
  36. GBD 2013 Stroke Panel Experts Group. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study. Neuroepidemiology. 2015;45(3):190-202.
  37. GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013. Neuroepidemiology. 2015;45(3):203-14.
  38. GBD 2013 Stroke Panel Experts Group. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study. Neuroepidemiology. 2015;45(3):230-6.
  39. GBD 2013 Anemia Collaborators. The Global Burden of Anemia. Hematol Oncol Clin North Am. 2016 Apr;30(2):247-308.
  40. GBD 2013 Collaborators. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016 Sep 10;388(10049):1081-1088.
  41. GBD 2010 Collaborators. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2224-60.
  42. GBD 2010 Collaborators. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2197-223.
  43. GBD 2010 Collaborators. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2163-96.
  44. GBD 2010 Collaborators. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2129-43.
  45. Malekzadeh R. Global Burden of Disease Study 2010: a real advance in global descriptive epidemiology: prospective for developing countries. Arch Iran Med. 2014 May;17(5):302-3.

 

 

: مقالات مرتبط با بار بیماری ها در منطقه خاورمیانه

 

  1. GBD 2015 Eastern Mediterranean Region Transportation Injuries Collaborators. Transport injuries and deaths in the Eastern
  2. Mediterranean Region: findings from the Global Burden of Disease 2015 Study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-0987-0.
  3. GBD 2015 Eastern Mediterranean Region Cancer Collaborators, Fitzmaurice C. Burden of cancer in the Eastern Mediterranean Region, 2005-2015: findings from the Global Burden of Disease 2015 Study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-0999-9.
  4. GBD 2015 Eastern Mediterranean Region Adolescent Health Collaborators. Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1003-4.
  5. GBD 2015 Eastern Mediterranean Region Maternal Mortality Collaborators. Maternal mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1004-3.
  6. GBD 2015 Eastern Mediterranean Region Intentional Injuries Collaborators. Intentional injuries in the Eastern Mediterranean Region, 1990-2015: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1005-2.
  7. GBD 2015 Eastern Mediterranean Region Vision Loss Collaborators. Burden of vision loss in the Eastern Mediterranean region, 1990-2015: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1000-7.
  8. GBD 2015 Eastern Mediterranean Region HIV/AIDS Collaborators. Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990-2015: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1023-0.
  9. GBD 2015 Eastern Mediterranean Region Mental Health Collaborators. The burden of mental disorders in the Eastern Mediterranean region, 1990-2015: findings from the global burden of disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1006-1.
  10. GBD 2015 Eastern Mediterranean Region LRI Collaborators. Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study. Int J Public Health.2017 Aug 3. doi: 10.1007/s00038-017-1007-0.
  11. GBD 2015 Eastern Mediterranean Region Cardiovascular Disease Collaborators. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990-2015: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1012-3.
  12. GBD 2015 Eastern Mediterranean Region Obesity Collaborators. Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1002-5.
  13. GBD 2015 Eastern Mediterranean Region Neonatal, Infant, and under-5 Mortality Collaborators. Neonatal, infant, and under-5 mortality and morbidity burden in the Eastern Mediterranean region: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi:10.1007/s00038-017-0998-x.
  14. GBD 2015 Eastern Mediterranean Region Diabetes and CKD Collaborators. Diabetes mellitus and chronic kidney disease in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1014-1.
  15. GBD 2015 Eastern Mediterranean Region Diarrhea Collaborators. Burden of diarrhea in the Eastern Mediterranean Region, 1990-2015: Findings from the Global Burden of Disease 2015 study. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1008-z.
  16. GBD 2015 Eastern Mediterranean Region Collaborators. Danger ahead: the burden of diseases, injuries, and risk factors in the Eastern Mediterranean Region, 1990-2015. Int J Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1017-y.
  17. GBD 2013 Collaborators. Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013. Ann Rheum Dis. 2017 Aug;76(8):1365-1373.
  18. GBD 2013 Collaborators. Burden of Diarrhea in the Eastern Mediterranean Region, 1990-2013: Findings from the Global Burden of Disease Study 2013. Am J Trop Med Hyg. 2016 Dec 7;95(6):1319-1329.
  19. GBD 2013 Collaborators. Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health. 2016 Oct;4(10):e704-13.

 

: فهرست مقالات مرتبط با بار بیماری ها  در ایران در مقایسه با کشورهای همسایه

 

  1. Karimkhani C, Dellavalle RP, Karimi SM, Rahimi-Movaghar V, Pourmalek F, Kiadaliri AA, Sahraian MA, Roshandel G, Fereshtehnejad SM, Qorbani M, Radfar A, Farvid MS, Asayesh H, Sepanlou SG, Djalalinia S, Kasaeian A, Khubchandani J, Malekzadeh R, Moradi-Lakeh M, Krohn KJ, Mokdad AH, Vos T, Naghavi M. Burden of Skin and Subcutaneous Diseases in Iran and Neighboring Countries: Results from the Global Burden of Disease Study 2015. Arch Iran Med. 2017 Jul;20(7):429-440.
  2. Moradi-Lakeh M, Sepanlou SG, Karimi SM, Khalili N, Djalalinia S, Karimkhani C, Krohn K, Afshin A, Farzadfar F, Vos T, Malekzadeh R, Mokdad AH, Murray CJL, Naghavi M. Trend of Socio-Demographic Index and Mortality Estimates in Iran and its Neighbors, 1990-2015; Findings of the Global Burden of Diseases 2015 Study. Arch Iran Med. 2017 Jul;20(7):419-428.
  3. Sepanlou SG, Parsaeian M, Krohn KJ, Afshin A, Farzadfar F, Roshandel G, Vos T, Murray CJL, Moradi-Lakeh M, Naghavi M, Malekzadeh R. Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015. Arch Iran Med. 2017 Jul;20(7):403-418.
  4. Djalalinia S, Saeedi Moghaddam S, Moradi-Lakeh M, Shahraz S, Naghavi M, Murray CJL, Vos T, Mokhdad AH, Krohn K, Danaei G, Afshin A, Sepanlou SG, Malekzadeh R, Farzadfar F. Prevalence and Years Lived with Disability of 310 Diseases and Injuries in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015. Arch Iran Med. 2017 Jul;20(7):392-402.
  5. Sepanlou SG, Malekzadeh F, Delavari F, Naghavi M, Forouzanfar MH, Moradi-Lakeh M, Malekzadeh R, Poustchi H, Pourshams A. Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010. Middle East J Dig Dis. 2015 Oct;7(4):201-15.
  6. Malekzadeh F, Sepanlou SG, Poustchi H, Naghavi M, Forouzanfar MH, Shahraz S,  Moradi-Lakeh M, Malekzadeh R. Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010. Middle East J Dig Dis. 2015 Jul;7:138-54.
  7. Sepanlou SG, Malekzadeh F, Naghavi M, Forouzanfar MH, Shahraz S, Moradi-Lakeh M, Malekzadeh R, Poustchi H. Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010. Middle East J Dig Dis. 2015 Jul;7:121-37.
  8. Shahraz S, Forouzanfar MH, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, Mokdad A, Lozano R, Vos T, Asadi-Lari M, Sayyari AA, Murray CJ, Naghavi M. Population health and burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon. Arch Iran Med. 2014 May;17(5):336-42.
  9. Naghavi M, Shahraz S, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, Mokdad A, Lozano R, Vos T, Asadi-Lari M, Sayyari AA, Murray CJ, Forouzanfar MH. Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med. 2014 May;17(5):321-35.
  10. Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F, Mokdad A, Lozano R, Vos T, Asadi-Lari M, Sayyari AA, Murray CJ, Naghavi M. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med. 2014 May;17(5):304-20.

 

 

«همکاری با گروه مطالعاتی عوامل خطر بیماری های مزمن غیرواگیر «امپریال کالج لندن

 

پژوهشکده بیماری های گوارش و کبد دانشگاه علوم پزشکی تهران همچنین از سال 2015 با گروه مطالعاتی عوامل خطر بیماری های مزمن غیرواگیر « امپریال کالج لندن» همکاری  تحقیقاتی داشته است که حاصل آن انتشار  6 مقاله در مجله معتبر بین المللی « لنست » بوده است

 

فهرست مقالات مرتبط با عوامل خطر بیماری های مزمن «امپریال کالج لندن» :

 

  1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity
  2. from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017 Dec 16;390(10113):2627-2642.
  3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017 Jan 7;389(10064):37-55.
  4. NCD Risk Factor Collaboration (NCD-RisC). A century of trends in adult human height. Elife. 2016 Jul 26;5. pii: e13410. doi: 10.7554/eLife.13410.
  5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016 Apr 9;387(10027):1513-30.
  6. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015 Aug;3(8):624-37
مطالب مشابه